This is why Alignment Healthcare Inc (ALHC) Stock is one of the options for the Longer run

Alignment Healthcare Inc [ALHC] stock prices are up 1.24% to $11.45 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ALHC shares have gain 4.85% over the last week, with a monthly amount drifted -1.12%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Previously, BofA Securities upgraded its rating to Buy on May 30, 2024, and elevated its price target to $11. On May 30, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $10 on the stock. Piper Sandler upgraded its rating to a Overweight and increased its price target to $8 on May 08, 2024. Barclays initiated its recommendation with a Underweight and recommended $4.50 as its price target on March 06, 2024. Piper Sandler downgraded its rating to Neutral for this stock on March 06, 2024, and downed its price target to $6. In a note dated January 24, 2024, Stifel initiated an Buy rating and provided a target price of $11 on this stock.

The stock price of Alignment Healthcare Inc [ALHC] has been fluctuating between $4.46 and $12.36 over the past year. Currently, Wall Street analysts expect the stock to reach $9.5 within the next 12 months. Alignment Healthcare Inc [NASDAQ: ALHC] shares were valued at $11.45 at the most recent close of the market. An investor can expect a potential drop of -17.03% based on the average ALHC price forecast.

Analyzing the ALHC fundamentals

The Alignment Healthcare Inc [NASDAQ:ALHC] reported sales of 2.23B for trailing twelve months, representing a surge of 47.34%. Gross Profit Margin for this corporation currently stands at 0.11% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -1.02 and Total Capital is -0.38. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.71.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.10 points at the first support level, and at 10.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.66, and for the 2nd resistance point, it is at 11.86.

Ratios To Look Out For

It’s worth pointing out that Alignment Healthcare Inc [NASDAQ:ALHC]’s Current Ratio is 1.61. Considering the valuation of this stock, the price to sales ratio is 0.98, the price to book ratio is 17.70.

Transactions by insiders

Recent insider trading involved Kim Hyong, Chief Medical Officer, that happened on Oct 08 ’24 when 22460.0 shares were sold. Chief Executive Officer, KAO JOHN E completed a deal on Oct 09 ’24 to sell 90000.0 shares. Meanwhile, Chief Financial Officer Freeman Robert Thomas sold 39320.0 shares on Oct 08 ’24.

Related Posts